PSYENCE BIOMEDICAL LTD.

PSYENCE BIOMEDICAL LTD. (PBMWW) shows no detected cyber incidents or red-flag 8-K filings in our 90-day observation window, suggesting operational stability on near-term governance metrics. However, low signal in a three-month window does not indicate absence of risk; biomedical companies face persistent dilution and financing pressures that require deeper context. The full $49 Report extends analysis to twelve months, calculates dilution risk scores across historical financing rounds, contextualizes any 8-K events within company narrative, and surfaces AI-detected risk signals in sector dynamics and cash runway. The full $49 Report adds quantified dilution trajectory, complete financing history, and forward-looking risk scoring.